Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase
NCT02259738
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Cerebral Infarction
Interventions
DRUG:
Human Urinary Kallidinogenase
DRUG:
Shuxuening injection
Sponsor
XuanwuH 2